Ayala Pharmaceuticals Inc (ADXS)
0.572
0.00 (0.00%)
USD |
OTCM |
Apr 19, 14:09
Ayala Pharmaceuticals Total Assets (Quarterly): 16.58M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 16.58M |
September 30, 2023 | 6.981M |
June 30, 2023 | 12.15M |
December 31, 2022 | 7.769M |
September 30, 2022 | 14.26M |
June 30, 2022 | 24.02M |
March 31, 2022 | 30.65M |
December 31, 2021 | 41.13M |
Date | Value |
---|---|
September 30, 2021 | 45.74M |
June 30, 2021 | 48.47M |
March 31, 2021 | 59.23M |
December 31, 2020 | 45.83M |
September 30, 2020 | 53.39M |
June 30, 2020 | 60.28M |
March 31, 2020 | 15.16M |
December 31, 2019 | 20.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.981M
Minimum
Sep 2023
60.28M
Maximum
Jun 2020
31.36M
Average
27.34M
Median
Total Assets (Quarterly) Benchmarks
Taro Pharmaceutical Industries Ltd | 2.163B |
InspireMD Inc | 47.64M |
BiomX Inc | 25.03M |
Alpha Tau Medical Ltd | 107.39M |
Pluri Inc | 41.56M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 41.00M |
Shareholders Equity (Quarterly) | -24.42M |